tetano
Editor, Senior Moderator
Curr Opin Infect Dis. 2013 Aug;26(4):366-377.
Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis.
Kaltsas A, Sepkowitz K.
Source
Division of Infectious Diseases, Memorial Sloan Kettering Cancer Cente, New York, New York, USA.
Abstract
PURPOSE OF REVIEW:
Healthcare personnel (HCP) are at risk for exposure to and transmission of potentially life-threatening vaccine preventable diseases to patients and colleagues. The Centers for Disease Control and Advisory Committee on Immunization Practices (ACIP) recommend routine influenza immunization and maintenance of immunity to hepatitis B and pertussis, among others. In this article, we aim to review recently approved influenza vaccines, as well as address some of the issues regarding hepatitis B and pertussis vaccinations in HCP.
RECENT FINDINGS:
Several new formulations of influenza vaccines are now available, including quadrivalent vaccines and non-egg-based vaccines; their use in HCP requires further study. An alarming rise in pertussis rates has led to a revision of ACIP guidelines recommending vaccination for women during each pregnancy. Persistent lack of immunity to hepatitis B after vaccine series remains a problem for many HCP.
SUMMARY:
Inactivated trivalent influenza vaccines remain the safest and most widely studied influenza vaccinations for healthcare workers. A pertussis booster in the form of Tdap is now recommended for most HCP. More studies are needed regarding the issue of nonresponders in HCP who receive the three-dose hepatitis B vaccine series, as there are some promising strategies available that may boost immune responses.
PMID:
23806899
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23806899
Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis.
Kaltsas A, Sepkowitz K.
Source
Division of Infectious Diseases, Memorial Sloan Kettering Cancer Cente, New York, New York, USA.
Abstract
PURPOSE OF REVIEW:
Healthcare personnel (HCP) are at risk for exposure to and transmission of potentially life-threatening vaccine preventable diseases to patients and colleagues. The Centers for Disease Control and Advisory Committee on Immunization Practices (ACIP) recommend routine influenza immunization and maintenance of immunity to hepatitis B and pertussis, among others. In this article, we aim to review recently approved influenza vaccines, as well as address some of the issues regarding hepatitis B and pertussis vaccinations in HCP.
RECENT FINDINGS:
Several new formulations of influenza vaccines are now available, including quadrivalent vaccines and non-egg-based vaccines; their use in HCP requires further study. An alarming rise in pertussis rates has led to a revision of ACIP guidelines recommending vaccination for women during each pregnancy. Persistent lack of immunity to hepatitis B after vaccine series remains a problem for many HCP.
SUMMARY:
Inactivated trivalent influenza vaccines remain the safest and most widely studied influenza vaccinations for healthcare workers. A pertussis booster in the form of Tdap is now recommended for most HCP. More studies are needed regarding the issue of nonresponders in HCP who receive the three-dose hepatitis B vaccine series, as there are some promising strategies available that may boost immune responses.
PMID:
23806899
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23806899